menu search

Does elon musk's investment make twitter a serious buyout candidate?

Twitter Inc (NYSE: TWTR) shares are up 30.4% this week after Tesla Inc (NASDAQ: TSLA) CEO and world's richest man Elon Musk disclosed a new 9.2% owne...

April 5, 2022, 5:41 pm

Precigen (pgen) up on fda fast track tag for car-t candidate

Precigen (PGEN) is developing CAR T therapy candidate, PRGN-3006 UltraCAR-T, for treating acute myeloid...

April 5, 2022, 10:32 am

5 short squeeze candidates to watch: guardforce ai tops list, newegg rejoins

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily s...

April 4, 2022, 12:06 pm

Reata (reta) submits nda for friedreich's ataxia candidate

Reata (RETA) is seeking approval for omaveloxolone as a treatment for neuromuscular disorder Friedreich's ataxia. It completes the rolling submission ...

April 4, 2022, 11:18 am

Xphyto therapeutics advancing rotigotine transdermal patch towards final pivotal study in fourth quarter this year

XPhyto Therapeutics Corp has updated on the progress of its Rotigotine transdermal (TDS) patch product candid...

April 4, 2022, 8:00 am

Applied therapeutics to present at the 43rd annual meeting of the society for inherited metabolic disorders

NEW YORK, April 04, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeli...

April 4, 2022, 7:30 am

Silverback therapeutics axes lead immuno-oncology candidates, lays off 27% workforce

Silverback Therapeutics Inc (NASDAQ: SBTX) undertakes “strategic realignment,” revealing it would drop its two lead cancer programs and lays of...

April 1, 2022, 11:20 am

Why ocugen stock is jumping today

The company dosed the first patient in a phase 1/2 study of its gene therapy candidate targeting a rare...

April 1, 2022, 11:19 am

Aim immunotech reports ‘strong' balance sheet to fund operations and clinical development programs through 2023

AIM ImmunoTech Inc (NYSE:AIM) said it has a “strong” balance sheet that will fund operations and clinical development programs through 2023.  In ...

April 1, 2022, 8:54 am

Immuneering announces participation in piper sandler ai/ml investor conference

CAMBRIDGE, Mass., April 01, 2022 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company using translational bioinform...

April 1, 2022, 6:50 am

Genprex announces opening of patient enrollment for its acclaim-2 clinical trial

Genprex Inc said it has opened patient enrollment for its Acclaim-2 clinical trial evaluating the company's lead drug ...

March 31, 2022, 9:54 am

Biogen (biib), ionis to end early-stage als candidate development

Biogen (BIIB) & partner Ionis (IONS) to terminate the development of their antisense ALS candidate, as ...

March 29, 2022, 2:18 pm

Moderna could have a big problem on its hands

The not-so-great side effects of Moderna's flu vaccine candidate could have greater implications....

March 29, 2022, 5:56 am

Could amylyx pharmaceuticals have a blockbuster als treatment?

The FDA's currently looking at an application for the company's lead candidate....

March 29, 2022, 5:45 am

Provention bio's coxsackievirus vaccine candidate elicits durable virus-neutralizing antibodies at six months

Provention Bio Inc (NASDAQ: PRVB) announced results from the final analysis of its first-in-human PROVENT study of PRV-101, a polyvalent inactivate...

March 28, 2022, 3:32 pm

5 short squeeze candidates to watch: indonesia energy gives way to a new oil stocks

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily s...

March 28, 2022, 10:15 am

Aim immunotech says data from ampligen study on pancreatic cancer accepted for presentation at upcoming ihpba world congress

AIM ImmunoTech Inc (NYSE:AIM) said data from a study evaluating the direct effects of its flagship drug cand...

March 28, 2022, 9:18 am

Which company has the biggest covid program? the answer isn't moderna.

Another player has stuffed its pipeline with many coronavirus candidates....

March 27, 2022, 8:00 am

Why icosavax's shares are trading lower today

Icosavax Inc (NASDAQ: ICVX) has announced topline interim results from its ongoing Phase 1/2 trial of IVX-411, a VLP vaccine ...

March 25, 2022, 9:16 am

Novavax's covid-19 booster to be evaluated in nih study

Novavax Inc. NVAX, +1.58% said Friday that its experimental COVID-19 booster is being tested in a Phase 1/2 clinical trial sponsored by the National I...

March 25, 2022, 8:46 am


Search within

Pages Search Results: